Proton beam therapy of stage II and III non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages 979-984

  Nakayama, Hidetsugu ^a,c   Satoh, Hiroaki ^b   Sugahara, Shinji ^a,c   Kurishima, Koichi ^b   Tsuboi, Koji ^a   Sakurai, Hideyuki ^a   Ishikawa, Shigemi ^b   Tokuuye, Koichi ^a,c  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

lung cancer; non small cell lung cancer; Proton; Stage III

Indexed keywords

CO-EXISTING; DISTANT METASTASIS; LOCAL CONTROL; LOCAL RECURRENCE; LOW TOXICITY; LUNG CANCER; NON SMALL CELL LUNG CANCER; OBSERVATION PERIOD; OVERALL SURVIVAL RATES; PROGRESSION FREE SURVIVAL; PROTON BEAM THERAPY; PROTON DOSE; RELATIVE BIOLOGIC EFFECTIVENESS;

BIOLOGICAL ORGANS; CHEMOTHERAPY; DISEASE CONTROL; DISEASES; PROTON BEAMS; PROTONS; TOXICITY;

PATIENT TREATMENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; ESOPHAGITIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTON THERAPY; RADIATION DOSE; RETROSPECTIVE STUDY; SKIN TOXICITY; SURVIVAL RATE; THERAPY EFFECT; TREATMENT REFUSAL;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROTONS; RADIOTHERAPY DOSAGE; RELATIVE BIOLOGICAL EFFECTIVENESS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 80255134578     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.024     Document Type: Article

References (28)

1. T. Matsuda, T. Marugame, and K. Kamo Cancer incidence and incidence rates in Japan in 2002: Based on data from 11 population-based cancer registries Jpn J Clin Oncol 38 2008 641 648
2. P. Yang, M.S. Allen, and M.C. Aubry Clinical features of 5,628 primary lung cancer patients: Experience at Mayo Clinic from 1997 to 2003 Chest 128 2005 452 462 (Pubitemid 40994510)
3. H. Suit, and M. Urie Proton beams in radiation therapy J Natl Cancer Inst 84 1992 155 164
4. H. Paganetti, A. Niemierko, and M. Ancukiewicz Relative biological effectiveness (RBE) values for proton beam therapy Int J Radiat Oncol Biol Phys 53 2002 407 421 (Pubitemid 34522107)
5. National Cancer Institute Cancer Therapy Evaluation Program NCI Guidelines - Expedited adverse event reporting requirements for NCI investigational agents 2001 National Cancer Institute Bethesda
6. Y. Tsunashima, T. Sakae, and Y. Shioyama Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy Int J Radiat Oncol Biol Phys 60 2004 951 958 (Pubitemid 39311777)
7. H. Asamura, T. Goya, and Y. Koshiishi A Japanese Lung Cancer Registry study: Prognosis of 13,010 resected lung cancers J Thorac Oncol 3 2008 46 52
8. D. Lardinois, H. Suter, and H. Hakki Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer Ann Thorac Surg 80 2005 268 274 265
9. K. Suzuki, K. Nagai, and J. Yoshida Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer J Thorac Cardiovasc Surg 117 1999 593 598 (Pubitemid 29117542)
10. R.S. Pritchard, and S.P. Anthony Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer: A meta-analysis Ann Intern Med 125 1996 723 729 (Pubitemid 126450359)
11. P. Marino, A. Preatoni, and A. Cantoni Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: A meta-analysis Cancer 76 1995 593 601
12. W. Curran Jr., C.B. Scott, and C.J. Langer Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiotherapy for patients with unresected stage III NSCLC: RTOG 9410 Proc Am Soc Clin Oncol 22 2003 621
13. P. Fournel, G. Robinet, and P. Thomas Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 study J Clin Oncol 23 2005 5910 5917
14. K. Furuse, M. Fukuoka, and M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699 (Pubitemid 29415225)
15. J.R. Jett, S.E. Schild, and R.L. Keith Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 266S 276S (Pubitemid 47502812)
16. P. Zatloukal, L. Petruzelka, and M. Zemanova Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study Lung Cancer 46 2004 87 98 (Pubitemid 39201387)
17. J.Y. Chang, X. Zhang, and X. Wang Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 2006 1087 1096
18. M. Saunders, S. Dische, A. Barrett for the CHART Steering Committee Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial Radiother Oncol 52 1999 137 148 (Pubitemid 29461081)
19. S.S. Yom, Z. Liao, and H.H. Liu Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 68 2007 94 102 (Pubitemid 46589835)
20. J.A. Hayman, M.K. Martel, and R.K. Ten Haken Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial J Clin Oncol 19 2001 127 136 (Pubitemid 32063489)
21. S. Senan, J. Van Sornsen de Koste, and M. Samson Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer Radiother Oncol 53 1999 247 255
22. S. Sim, K.E. Rosenzweig, and R. Schindelheim Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer Int J Radiat Oncol Biol Phys 51 2001 660 665
23. F.M. Kong, R.K. Ten Haken, and M.J. Schipper High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study Int J Radiat Oncol Biol Phys 63 2005 324 333 (Pubitemid 41317147)
24. J.D. Bradley, K. Bae, and N. Choi A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): Primary analysis of Radiation Therapy Oncology Group (RTOG) 0515 [Abstract] Int J Radiat Oncol Biol Phys 75 Suppl. 3 2009 2
25. M. Werner-Wasik, R.S. Swann, and J. Bradley Increasing tumor volume is predictive of poor overall and progression-free survival: Secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 385 390
26. J.G. Rosenman, J.S. Halle, and M.A. Socinski High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: Technical issues and results of a phase I/II trial Int J Radiat Oncol Biol Phys 54 2002 348 356 (Pubitemid 35286797)
27. S.E. Schild, W.L. McGinnis, and D. Graham Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 2006 1106 1111
28. M.A. Socinski, A.W. Blackstock, and J.A. Bogart Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105 J Clin Oncol 26 2008 2457 2463